Key facts
- It has raised $4.3M; the latest was Early Stage VC ($3.8M) in Oct 2025.
- Notable investors include Y Combinator, Transpose Platform Management, Phosphor Capital, Boling Jiang, David Parker — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Newton
- ·The full record, as it builds
Funding rounds
No funding rounds for Newton are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Newton
Developer of an AI-based scheduling tool intended to help private dental practitioners automate their scheduling. The company's tool coordinates directly with patients to handle key scheduling tasks with the help of features including personalized re-engagement for overdue patients and end-to-end patient tracking for arrivals and cancellations, enabling users to offer a seamless scheduling experience for patients.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Employees
- 9
- Website
- joinnewton.com/
- Ownership
- Privately Held (backing)
Newton doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Newton shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Newton in its N-PORT filings yet. We sweep new filings monthly.